803 results found

On 1 July 2025, the Secretary of State for Finance submitted a letter to Parliament addressing alternative proposals regarding the current lucrative interest scheme (the "Letter").

Het is een doorn in het oog, ook in de IE-wereld: ondernemingen die nepfacturen sturen of het idee geven u een interessant aanbod te doen,...

As the private equity industry continues to adjust to the unprecedented challenges of COVID-19, the economic impact of this global healthcare crisis raises many questions about how companies

CGLytics has released its inaugural S&P 500 Executive Compensation Review. For companies and investors to be fully prepared with insights for the upcoming proxy season...

The use of pre-wired back-end measures has become a well-established part of transaction structures when a public bid is launched for a Dutch listed company.

When you are wrapped up in the here and now, tackling questions like how your business will emerge from the pandemic, it's easy to view compliance as red tape that gets in the way of your recovery.

But the impact of moving people to work in a different country should not be overlooked.

Time – and lack of it – is one of the biggest constraints for international companies looking to obtain public registry documents from the Benelux region.

Companies and M&A advisors that participate in carve-outs and M&A deals are underestimating certain elements of the process which can be detrimental to the transactions and ultimately the success of the new company.

In recent decades, supply chains have become longer and more complex due to globalization. Access to global markets and the ability to manufacture in low-wage countries...

The Dutch House of Representatives has adopted a private member's bill introducing call-in powers for the Dutch competition authority ACM, enabling review of below-threshold transactions while simultaneously raising mandatory notification thresholds. This reform shifts Dutch merger control from a purely threshold-based system toward a discretionary, risk-based regime that could significantly impact dealmakers pursuing roll-up strategies, buy-and-build models, or acquisitions in concentrated markets.